Using a data analysis of the relationship between GATA6 and various parameters of endometrial cancer, the findings showed that the expression rates of GATA6 in endometrial cancer tissues, atypical endometrial hyperplasia tissues, and normal endometrial tissues were 63.4%, 18.3%, and 6.0%, respectively. Here, GATA6 is linked to atypical endometrial hyperplasia.